Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Mainwaring

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Prostate International|February 10, 2016
Emerging perspectives in prostate cancer: Insights from the 4th Asia Pacific Prostate Cancer ConferencePaul Mainwaring, Hideyuki Akaza
European Urology|May 29, 2016
Integrating Molecular Profiling of Liquid Biopsy Samples with a Calculator Algorithm To Detect High-risk Prostate CancerRobert A Gardiner, Paul Mainwaring, Martin F Lavin
ACS Applied Materials & Interfaces|February 26, 2019
Reading Conformational Changes in Proteins with a New Colloidal-Based Interfacial Biosensing SystemMostak Ahmed, Laura G Carrascosa, Paul Mainwaring, et al.
Cancers|February 15, 2022
Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?Eric Jonasch, Michael B Atkins, Simon Chowdhury, et al.
Lancet (London, England)|June 28, 2002
Is the NICE process flawed?Jim Cassidy, John Bridgewater, Paul Mainwaring, et al.
Biomaterials Science|July 20, 2018
An exosomal- and interfacial-biosensing based strategy for remote monitoring of aberrantly phosphorylated proteins in lung cancer cellsMostak Ahmed, Laura G Carrascosa, Alain Wuethrich, et al.
Trials|March 8, 2007
Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapyVera Hirsh, John Glaspy, Paul Mainwaring, et al.
Frontiers in Oncology|September 14, 2020
Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid TumorsSimon Chowdhury, Paul Mainwaring, Liangcai Zhang, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 2, 2006
Online referral and OPD booking from the GP desktopCaroline Nicholson, Claire L Jackson, Bernadette Wright, et al.
Investigational New Drugs|February 18, 2011
Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxelMichael Millward, Paul Mainwaring, Alain Mita, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Prostate International|February 10, 2016
Emerging perspectives in prostate cancer: Insights from the 4th Asia Pacific Prostate Cancer ConferencePaul Mainwaring, Hideyuki Akaza
European Urology|May 29, 2016
Integrating Molecular Profiling of Liquid Biopsy Samples with a Calculator Algorithm To Detect High-risk Prostate CancerRobert A Gardiner, Paul Mainwaring, Martin F Lavin
ACS Applied Materials & Interfaces|February 26, 2019
Reading Conformational Changes in Proteins with a New Colloidal-Based Interfacial Biosensing SystemMostak Ahmed, Laura G Carrascosa, Paul Mainwaring, et al.
Cancers|February 15, 2022
Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?Eric Jonasch, Michael B Atkins, Simon Chowdhury, et al.
Lancet (London, England)|June 28, 2002
Is the NICE process flawed?Jim Cassidy, John Bridgewater, Paul Mainwaring, et al.
Biomaterials Science|July 20, 2018
An exosomal- and interfacial-biosensing based strategy for remote monitoring of aberrantly phosphorylated proteins in lung cancer cellsMostak Ahmed, Laura G Carrascosa, Alain Wuethrich, et al.
Trials|March 8, 2007
Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapyVera Hirsh, John Glaspy, Paul Mainwaring, et al.
Frontiers in Oncology|September 14, 2020
Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid TumorsSimon Chowdhury, Paul Mainwaring, Liangcai Zhang, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 2, 2006
Online referral and OPD booking from the GP desktopCaroline Nicholson, Claire L Jackson, Bernadette Wright, et al.
Investigational New Drugs|February 18, 2011
Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxelMichael Millward, Paul Mainwaring, Alain Mita, et al.
Pageof 4